Phase 1, open label, single dose, parallel group study evaluating the pharmacokinetics, safety, and tolerability of amenamevir in healthy participants and participants with various degrees of renal impairment.

Trial Profile

Phase 1, open label, single dose, parallel group study evaluating the pharmacokinetics, safety, and tolerability of amenamevir in healthy participants and participants with various degrees of renal impairment.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Amenamevir (Primary)
  • Indications Herpes simplex virus infections; Herpes zoster
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Nov 2017 New trial record
    • 13 Nov 2017 Results published in the Advances in Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top